NCT01391962 2026-02-02
Sunitinib or Cediranib for Alveolar Soft Part Sarcoma
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
National Institutes of Health Clinical Center (CC)
The University of Texas Health Science Center at San Antonio
University of Arizona
Wake Forest University Health Sciences
Washington University School of Medicine
Amryt Pharma